Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2398572178;72179;72180 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
N2AB2234467255;67256;67257 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
N2A2141764474;64475;64476 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
N2B1492044983;44984;44985 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
Novex-11504545358;45359;45360 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
Novex-21511245559;45560;45561 chr2:178574179;178574178;178574177chr2:179438906;179438905;179438904
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-62
  • Domain position: 62
  • Structural Position: 92
  • Q(SASA): 0.2343
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I None None 1.0 N 0.833 0.551 0.663365763907 gnomAD-4.0.0 2.73727E-06 None None None None N None 0 0 None 0 0 None 0 0 3.59826E-06 0 0
T/R None None 1.0 N 0.835 0.525 0.78875543026 gnomAD-4.0.0 6.84318E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99565E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1125 likely_benign 0.1237 benign -0.838 Destabilizing 0.999 D 0.55 neutral N 0.49763393 None None N
T/C 0.4828 ambiguous 0.4891 ambiguous -0.498 Destabilizing 1.0 D 0.793 deleterious None None None None N
T/D 0.5656 likely_pathogenic 0.5753 pathogenic 0.24 Stabilizing 1.0 D 0.823 deleterious None None None None N
T/E 0.366 ambiguous 0.3845 ambiguous 0.233 Stabilizing 1.0 D 0.819 deleterious None None None None N
T/F 0.3801 ambiguous 0.4437 ambiguous -1.047 Destabilizing 1.0 D 0.875 deleterious None None None None N
T/G 0.4639 ambiguous 0.4881 ambiguous -1.068 Destabilizing 1.0 D 0.775 deleterious None None None None N
T/H 0.3716 ambiguous 0.3959 ambiguous -1.317 Destabilizing 1.0 D 0.857 deleterious None None None None N
T/I 0.165 likely_benign 0.1816 benign -0.325 Destabilizing 1.0 D 0.833 deleterious N 0.497126951 None None N
T/K 0.3337 likely_benign 0.3571 ambiguous -0.512 Destabilizing 1.0 D 0.823 deleterious D 0.525642421 None None N
T/L 0.1322 likely_benign 0.1471 benign -0.325 Destabilizing 0.999 D 0.696 prob.neutral None None None None N
T/M 0.0975 likely_benign 0.112 benign -0.107 Destabilizing 1.0 D 0.789 deleterious None None None None N
T/N 0.215 likely_benign 0.2315 benign -0.461 Destabilizing 1.0 D 0.722 prob.delet. None None None None N
T/P 0.2457 likely_benign 0.2599 benign -0.464 Destabilizing 1.0 D 0.836 deleterious N 0.506218758 None None N
T/Q 0.2825 likely_benign 0.2968 benign -0.598 Destabilizing 1.0 D 0.844 deleterious None None None None N
T/R 0.2756 likely_benign 0.2989 benign -0.325 Destabilizing 1.0 D 0.835 deleterious N 0.486277624 None None N
T/S 0.1564 likely_benign 0.1694 benign -0.798 Destabilizing 0.999 D 0.522 neutral N 0.503545732 None None N
T/V 0.1318 likely_benign 0.1373 benign -0.464 Destabilizing 0.999 D 0.598 neutral None None None None N
T/W 0.749 likely_pathogenic 0.7974 pathogenic -0.964 Destabilizing 1.0 D 0.847 deleterious None None None None N
T/Y 0.4543 ambiguous 0.4945 ambiguous -0.718 Destabilizing 1.0 D 0.865 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.